Clinical trial
Escitalopram and Language Intervention for Subacute Aphasia (ELISA)
NCT03843463 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Escitalopram and Language Intervention for Subacute Aphasia (ELISA)
- Lead sponsor
- Johns Hopkins University
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- July 18, 2021
- Completion date
- June 18, 2027
- Enrollment
- 88 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.